Find an Eye MD near you!

Ophthotech announced that Genentech will join Novartis and split rights to pegpleranib (Fovista) for the treatment of wet AMD.

Allergan announced that its biodegradable sustained-release bimatoprost implant is comparable to daily topical bimatoprost.

The U.S. FDA has granted orphan drug designation to AGTC’s gene therapy product candidate for the treatment of achromatopsia caused by mutations in the CNGA3 gene.

A randomized trial from has shown ranibizumab is as effective as panretinal photocoagulation in treating PDR, and better than laser in preserving patients’ peripheral and night vision.

Long-term response to anti-VEGF therapy in DME may be predicted after 3 injections at 12 weeks

Pfizer today announced it reached a $160 billion deal to merge with Allergan.